Wed Feb 9, 2022 – 3:54 pm ESTWed Feb 9, 2022 – 4:15 pm EST
NEW YORK (LifeSiteNews) — Pfizer reported global sales and alliance revenue from its abortion-tainted COVID vaccine brought in $36.78 billion in 2021, helping to more than double profits across its business operations compared with 2020.
In an earnings report issued Tuesday, the pharmaceutical giant also estimated that sales of its vaccine and anti-viral pill will top $54 billion in 2022, buoying shareholders’ hopes that profits at the company might soar for the second year in a row.
Pfizer CEO Albert Bourla said the company plans to aggressively expand the use of messenger RNA beyond just COVID vaccines, pointing to potential treatments of muscle, the liver and nervous system, despite warnings from many researchers that the use of mRNA technology carries significant risks.
Despite record earnings, Pfizer shares fell 3% yesterday on Wall Street due to lower than expected 2022 sales forecasts for its anti-viral pill, Paxlovid, which it sells at $530 a course in the United States.
Anti-viral pills like ivermectin, which health chiefs have sought to ban or restrict, typically sell for a few dollars when available, with several scientists suggesting the
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors